Arkansas SB 192: TO AMEND THE LAW CONCERNING COVERAGE OF BIOSIMLAR MEDICAL PRODUCTS UNDER STEP THERAPY PROTOCOLS; AND TO AMEND EXCEPTIONS TO STEP THERAPY PROTOCOLS.

Status: Notification that SB192 is now Act 136 (as of 2023-02-27)

State: Arkansas · Session: 2023 · Bill: SB 192

Sponsors: Achor, J. Boyd

View Arkansas SB 192 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.